In September 2019, the Food and Drug Administration reported that N-nitrosodimethlylamine (NDMA) was discovered in Zantac (ranitidine). NDMA is considered a probable carcinogen by the Environmental Protection Agency and has been linked to an increased risk of cancer. Due to the FDA’s announcement, all Zantac and ranitidine products were removed from the market in April 2020.
If you developed some form of cancer due to Zantac, you might be entitled to financial compensation. The Guardian Legal Network helps people like you who have been wronged by negligent drug manufacturers and want to take legal action. We can connect you with an experienced law firm that will help you seek justice.